Skip to main content
C

CarthroniX

CarthroniX develops small molecule-based therapies that preserve and regenerate cartilage while suppressing inflammation, targeting degenerative diseases such as knee osteoarthritis. The company is also advancing treatments for idiopathic pulmonary fibrosis and skin regeneration to prevent tissue fibrosis in musculoskeletal tissues.

Lancaster, United StatesFounded 20153100+ followers
Updated 20 months ago

Funding

$4.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

PP
Funding rounds are not available yet.

Founders

Product

Problem

Osteoarthritis and other degenerative diseases lead to cartilage damage and inflammation in joints, causing pain and limited mobility. Current treatments often fail to regenerate cartilage effectively or address the underlying inflammation. Existing therapies for idiopathic pulmonary fibrosis and tissue fibrosis also have limitations in preventing disease progression.

Solution

CarthroniX is developing small molecule-based therapies designed to preserve, repair, and regenerate cartilage in joints while simultaneously suppressing inflammation. Their approach targets the underlying causes of degenerative diseases like knee osteoarthritis. In addition to osteoarthritis, CarthroniX is also creating novel solutions for idiopathic pulmonary fibrosis, skin regeneration, and the prevention of tissue fibrosis in musculoskeletal tissues.

Target Audience

The primary target audience includes individuals suffering from degenerative and aging-related diseases such as osteoarthritis, as well as those affected by idiopathic pulmonary fibrosis and tissue fibrosis.

Features

  • CX-011: A small molecule injectable therapeutic designed to halt or reverse the progression of mild-to-moderate knee osteoarthritis.
  • Small molecule therapies for canine oncology developed in partnership with Boehringer Ingelheim.
  • Novel technologies able to preserve, repair, and regenerate cartilage in joints.
  • Therapies that concurrently suppress inflammation.
  • Solutions for idiopathic pulmonary fibrosis.
  • Solutions for skin regeneration and prevention of tissue fibrosis in the skin and musculoskeletal tissues.
This profile is AI-generated and may contain inaccuracies.